|
325 Pharmacy
representation on PECs must not be lost It is essential that
clinical pharmacy leaders are part of reconfigured primary care trust
professional executive committees (PECs), say PEC pharmacists following
an announcement that the committees are here to stay but their form and
responsibilities may change
PJ 2006;277:325
Full Text
325 Flight security
measures criticised over insulin Recently introduced air travel
security restrictions may mean that passengers with diabetes have to
place their insulin in aeroplanes' holds and compromise their glycaemic
control, diabetes charities have warned
PJ 2006;277:325
Full Text
325 PSNC opposes further
easing of contract controls No more changes to the rules on applying
for new pharmacy contracts in England should be made, the Pharmaceutical Services
Negotiating Committee has told the Department of Health
PJ 2006;277:325
Full Text
326 Delays
will affect flu vaccine provision in Scotland Community pharmacists
in Scotland are being advised to work closely with GPs in order to minimise the
effect of delays with influenza vaccine production
PJ 2006;277:326
Full Text
326 SMC rejects Exubera
for use in NHS Scotland Pfizer's inhaled insulin Exubera has been
rejected for use in NHS Scotland by the Scottish Medicines Consortium
PJ 2006;277:326
Full Text
326 Martin Green elected
chairman of Scottish negotiating body Martin Green, an independent
pharmacy contractor, has been appointed chairman of the Scottish Pharmaceutical
General Council
PJ 2006;277:326
Full Text
326 Dressings price cuts
imposed Prices paid to pharmacy contractors in England and Wales by
the Department of Health for a range of dressings and blood glucose test strips
are to be cut from 1 October
PJ 2006;277:326
Full Text
327 Prescribers
of opiate-substitutes urged to link dosing to client needs Prescribers
continue to offer drug misuse clients insufficient doses of methadone to prevent
the use of illicit drugs, according to early results from a review of UK substance
misuse services
PJ 2006;277:327
Full Text
327 Stoma supplies should
be designated an optional service Representatives of pharmacy contractors
in England have told the Department of Health that they want the supply of stoma
and incontinence appliances and catheters to be an optional NHS service
PJ 2006;277:327
Full Text
327 Variations across
England in smoking cessation revealed Variations exist across England
in provision of smoking cessation services, according to the results of a review
published by the Healthcare Commission this week
PJ 2006;277:327
Full Text
328 Parallel
import case unresolved GlaxoSmithKline has been told that its quota
supply system in Greece does not contravene Greek competition law, but the question
of whether it is allowed under EU law remains unresolved
PJ 2006;277:328
Full Text
328 PAGB refocuses its
attention on members The Proprietary Association of Great Britain
is to stop providing consumer health information and is to refocus its work on
helping companies meet the new regulatory requirements of recent European pharmaceutical
legislation
PJ 2006;277:328
Full Text
328 Survey shows that
patients want clearer health information Members of patient groups
think it essential that both patients and their care-givers get information that
is easy to understand so that they can make properly informed decisions about
their treatment
PJ 2006;277:328
Full Text
329 New
poisoning statistics released Over a third of enquiries to the National Poisons Information Service involve children under 10 years of age, according to the service's 2005–06 report
PJ 2006;277:329
Full Text
329 Pharmacists told “focus on what you control” Pharmacists
should focus on things that are already within their control, for example, upgrading
IT systems, training pharmacy staff and investing in continuing professional
development, according to David Coles, managing director of UniChem
PJ 2006;277:329
Full Text
329 UniChem outlines increased
level of pharmacy support UniChem plans more support to help customers
make the most of commercial opportunities arising from the pharmacy contract
PJ 2006;277:329
Full Text
330 Data
support steroid use in COPD Use of inhaled corticosteroids to treat
patients with chronic obstructive pulmonary disease (COPD) reduces risk of death,
particularly from cardiovascular causes, according to research published
PJ 2006;277:330
Full Text
330 BOC's pursuit of cylinders
is unacceptable BOC's continued pursuit of cylinders it believes to
be lost or missing is unacceptable, the National Pharmacy Association argues
PJ 2006;277:330
Full Text
330 NPA launches price
service Members of the National Pharmacy Association have a new service
to help them judge whether they are getting a good deal when they buy generic
medicines
PJ 2006;277:330
Full Text
330 New pharmacy course
to start at the University of Wolverhampton later this month A new
MPharm course at the University of Wolverhampton is to start this month after
being accredited by the Royal Pharmaceutical Society
PJ 2006;277:330
Full Text
330 Celecoxib as chemopreventive Celecoxib
has no role as a chemopreventive agent in the general population or in patients
with non-familial colonic adenomas, say authors of an editorial commenting on
two trials published
PJ 2006;277:330
Full Text
330 “Measure up” campaign Diabetes
UK has launched 'Measure up', a campaign to encourage people to measure their
waistline as a first step to assessing their diabetes risk
PJ 2006;277:330
Full Text |
R&D News
331 On-demand SSRI for
premature ejaculation proves effective A selective serotonin reuptake
inhibitor developed specifically for on-demand treatment of premature ejaculation
has shown promising results in phase III trials
PJ 2006;277:331
Full Text
331 Immunomodulating agent
for MS promising A new oral immunomodulating agent called fingolimod
has shown promise in a proof-of-concept study for the treatment of relapsing
multiple sclerosis
PJ 2006;277:331
Full Text
331 Diabetes research
examines promise of therapeutic target A new therapeutic target for
type 2 diabetes has been tested in mice and could provide a future treatment
for people with the condition
PJ 2006;277:331
Full Text
331 “Caged” iron chelators tamed for dermatology applications Caged
iron chelators being developed as potential sunscreen ingredients may also have
applications for skin conditions, Charareh Pourzand, from Bath School of Pharmacy
and Pharmacology, has revealed to The Journal
PJ 2006;277:331
Full Text
331 H5N1 research gathers
pace The race to develop a vaccine against a future influenza pandemic
continues, with two new reports of progress published online
PJ 2006;277:331
Full Text |
The
Pharmaceutical Journal